A citation-based method for searching scientific literature

Synaptic Dysfunction in Huntington's Disease: Lessons from Genetic Animal Models.
Carlos Cepeda, Michael S Levine. Neuroscientist 2022
Times Cited: 12






Login to export Results
Don't have an account? Register here

List of co-cited articles
97 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.
. Cell 1993
5415
10
83

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.
L Mangiarini, K Sathasivam, M Seller, B Cozens, A Harper, C Hetherington, M Lawton, Y Trottier, H Lehrach, S W Davies,[...]. Cell 1996
2353
5
41

Huntington disease.
J P Vonsattel, M DiFiglia. J Neuropathol Exp Neurol 1998
1096
5
41

Cortical and Striatal Circuits in Huntington's Disease.
Sonja Blumenstock, Irina Dudanova. Front Neurosci 2020
22
4
33

Huntington disease.
Gillian P Bates, Ray Dorsey, James F Gusella, Michael R Hayden, Chris Kay, Blair R Leavitt, Martha Nance, Christopher A Ross, Rachael I Scahill, Ronald Wetzel,[...]. Nat Rev Dis Primers 2015
629
4
33

Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function.
L A Raymond, V M André, C Cepeda, C M Gladding, A J Milnerwood, M S Levine. Neuroscience 2011
203
4
33

The Biology of Huntingtin.
Frédéric Saudou, Sandrine Humbert. Neuron 2016
405
4
33

The Neuropathology of Huntington's Disease.
Henry J Waldvogel, Eric H Kim, Lynette J Tippett, Jean-Paul G Vonsattel, Richard L M Faull. Curr Top Behav Neurosci 2015
86
3
25

Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.
Michelle Gray, Dyna I Shirasaki, Carlos Cepeda, Véronique M André, Brian Wilburn, Xiao-Hong Lu, Jifang Tao, Irene Yamazaki, Shi-Hua Li, Yi E Sun,[...]. J Neurosci 2008
446
3
25

Nerve cell loss in the thalamic centromedian-parafascicular complex in patients with Huntington's disease.
H Heinsen, U Rüb, D Gangnus, G Jungkunz, M Bauer, G Ulmar, B Bethke, M Schüler, F Böcker, W Eisenmenger,[...]. Acta Neuropathol 1996
68
3
25

Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features.
Ina Han, YiMei You, Jeffrey H Kordower, Scott T Brady, Gerardo A Morfini. J Neurochem 2010
94
3
25

Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease.
Nan Wang, Michelle Gray, Xiao-Hong Lu, Jeffrey P Cantle, Sandra M Holley, Erin Greiner, Xiaofeng Gu, Dyna Shirasaki, Carlos Cepeda, Yuqing Li,[...]. Nat Med 2014
137
3
25

Striatal parvalbuminergic neurons are lost in Huntington's disease: implications for dystonia.
Anton Reiner, Evan Shelby, Hongbing Wang, Zena Demarch, Yunping Deng, Natalie Hart Guley, Virginia Hogg, Richard Roxburgh, Lynette J Tippett, Henry J Waldvogel,[...]. Mov Disord 2013
61
3
25

Differential electrophysiological changes in striatal output neurons in Huntington's disease.
Véronique M André, Carlos Cepeda, Yvette E Fisher, My Huynh, Nora Bardakjian, Sumedha Singh, X William Yang, Michael S Levine. J Neurosci 2011
97
3
25

Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease.
R L Albin, A Reiner, K D Anderson, L S Dure, B Handelin, R Balfour, W O Whetsell, J B Penney, A B Young. Ann Neurol 1992
261
3
25

Earliest functional declines in Huntington disease.
Leigh J Beglinger, Justin J F O'Rourke, Chiachi Wang, Douglas R Langbehn, Kevin Duff, Jane S Paulsen. Psychiatry Res 2010
89
3
25

Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease.
Damian M Cummings, Véronique M André, Besim O Uzgil, Steven M Gee, Yvette E Fisher, Carlos Cepeda, Michael S Levine. J Neurosci 2009
121
3
25

Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release.
He Li, Travis Wyman, Zhao-Xue Yu, Shi-Hua Li, Xiao-Jiang Li. Hum Mol Genet 2003
102
3
25

Integrative Characterization of the R6/2 Mouse Model of Huntington's Disease Reveals Dysfunctional Astrocyte Metabolism.
Niels H Skotte, Jens V Andersen, Alberto Santos, Blanca I Aldana, Cecilie W Willert, Anne Nørremølle, Helle S Waagepetersen, Michael L Nielsen. Cell Rep 2018
49
3
25

Mouse models of Huntington's disease and methodological considerations for therapeutic trials.
Robert J Ferrante. Biochim Biophys Acta 2009
98
2
16

The Neuropsychology of Huntington's Disease.
Julie S Snowden. Arch Clin Neuropsychol 2017
51
2
16

Therapy development in Huntington disease: From current strategies to emerging opportunities.
Audrey S Dickey, Albert R La Spada. Am J Med Genet A 2018
42
2
16

Genetic mouse models of Huntington's disease: focus on electrophysiological mechanisms.
Carlos Cepeda, Damian M Cummings, Véronique M André, Sandra M Holley, Michael S Levine. ASN Neuro 2010
61
2
16

Huntingtin Lowering Strategies for Disease Modification in Huntington's Disease.
Sarah J Tabrizi, Rhia Ghosh, Blair R Leavitt. Neuron 2019
88
2
16

Cholinergic interneurons mediate fast VGluT3-dependent glutamatergic transmission in the striatum.
Michael J Higley, Aryn H Gittis, Ian A Oldenburg, Nina Balthasar, Rebecca P Seal, Robert H Edwards, Bradford B Lowell, Anatol C Kreitzer, Bernardo L Sabatini. PLoS One 2011
125
2
16

Differential inputs to striatal cholinergic and parvalbumin interneurons imply functional distinctions.
Jason R Klug, Max D Engelhardt, Cara N Cadman, Hao Li, Jared B Smith, Sarah Ayala, Elora W Williams, Hilary Hoffman, Xin Jin. Elife 2018
43
2
16

Heterogeneity and Diversity of Striatal GABAergic Interneurons: Update 2018.
James M Tepper, Tibor Koós, Osvaldo Ibanez-Sandoval, Fatuel Tecuapetla, Thomas W Faust, Maxime Assous. Front Neuroanat 2018
81
2
16

Concurrent activation of striatal direct and indirect pathways during action initiation.
Guohong Cui, Sang Beom Jun, Xin Jin, Michael D Pham, Steven S Vogel, David M Lovinger, Rui M Costa. Nature 2013
671
2
16

Evidence for specific cognitive deficits in preclinical Huntington's disease.
A D Lawrence, J R Hodges, A E Rosser, A Kershaw, C ffrench-Constant, D C Rubinsztein, T W Robbins, B J Sahakian. Brain 1998
308
2
16

Inhibitory control of neostriatal projection neurons by GABAergic interneurons.
T Koós, J M Tepper. Nat Neurosci 1999
599
2
16

Striatal microcircuitry and movement disorders.
Aryn H Gittis, Anatol C Kreitzer. Trends Neurosci 2012
121
2
16

Heterogeneity and diversity of striatal GABAergic interneurons.
James M Tepper, Fatuel Tecuapetla, Tibor Koós, Osvaldo Ibáñez-Sandoval. Front Neuroanat 2010
277
2
16

Re-emergence of striatal cholinergic interneurons in movement disorders.
Antonio Pisani, Giorgio Bernardi, Jun Ding, D James Surmeier. Trends Neurosci 2007
309
2
16

Cholinergic interneurons in the Q140 knockin mouse model of Huntington's disease: Reductions in dendritic branching and thalamostriatal input.
Yun-Ping Deng, Anton Reiner. J Comp Neurol 2016
23
2
16

The functional anatomy of basal ganglia disorders.
R L Albin, A B Young, J B Penney. Trends Neurosci 1989
3628
2
16

Striatal interneurones: chemical, physiological and morphological characterization.
Y Kawaguchi, C J Wilson, S J Augood, P C Emson. Trends Neurosci 1995
920
2
16

Postsynaptic endocannabinoid release is critical to long-term depression in the striatum.
G L Gerdeman, J Ronesi, D M Lovinger. Nat Neurosci 2002
527
2
16

Enhanced GABAergic Inputs Contribute to Functional Alterations of Cholinergic Interneurons in the R6/2 Mouse Model of Huntington's Disease.
Sandra M Holley, Prasad R Joshi, Anna Parievsky, Laurie Galvan, Jane Y Chen, Yvette E Fisher, My N Huynh, Carlos Cepeda, Michael S Levine. eNeuro 2015
36
2
16

GABAergic inhibition in dual-transmission cholinergic and GABAergic striatal interneurons is abolished in Parkinson disease.
N Lozovaya, S Eftekhari, R Cloarec, L A Gouty-Colomer, A Dufour, B Riffault, M Billon-Grand, A Pons-Bennaceur, N Oumar, N Burnashev,[...]. Nat Commun 2018
38
2
16

Novel Striatal GABAergic Interneuron Populations Labeled in the 5HT3a(EGFP) Mouse.
A B Muñoz-Manchado, C Foldi, S Szydlowski, L Sjulson, M Farries, C Wilson, G Silberberg, J Hjerling-Leffler. Cereb Cortex 2016
43
2
16

Cholinergic neuronal defect without cell loss in Huntington's disease.
Ruben Smith, Hinfan Chung, Sara Rundquist, Marion L C Maat-Schieman, Lesley Colgan, Elisabet Englund, Yong-Jian Liu, Raymund A C Roos, Richard L M Faull, Patrik Brundin,[...]. Hum Mol Genet 2006
101
2
16

Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington's disease.
Joshua L Plotkin, Michelle Day, Jayms D Peterson, Zhong Xie, Geraldine J Kress, Igor Rafalovich, Jyothisri Kondapalli, Tracy S Gertler, Marc Flajolet, Paul Greengard,[...]. Neuron 2014
122
2
16

Multiple sources of striatal inhibition are differentially affected in Huntington's disease mouse models.
Carlos Cepeda, Laurie Galvan, Sandra M Holley, Shilpa P Rao, Véronique M André, Elian P Botelho, Jane Y Chen, Joseph B Watson, Karl Deisseroth, Michael S Levine. J Neurosci 2013
80
2
16

Degeneration of pyramidal projection neurons in Huntington's disease cortex.
M Cudkowicz, N W Kowall. Ann Neurol 1990
153
2
16

Disrupted striatal neuron inputs and outputs in Huntington's disease.
Anton Reiner, Yun-Ping Deng. CNS Neurosci Ther 2018
42
2
16

Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional Huntington's disease mouse model.
Tara E Wood, Joshua Barry, Zhenquin Yang, Carlos Cepeda, Michael S Levine, Michelle Gray. Hum Mol Genet 2019
45
2
16

Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease.
Prasad R Joshi, Nan-Ping Wu, Véronique M André, Damian M Cummings, Carlos Cepeda, John A Joyce, Jeffrey B Carroll, Blair R Leavitt, Michael R Hayden, Michael S Levine,[...]. J Neurosci 2009
129
2
16

Cortical circuit alterations precede motor impairments in Huntington's disease mice.
Johanna Burgold, Elena Katharina Schulz-Trieglaff, Kerstin Voelkl, Sara Gutiérrez-Ángel, Jakob Maximilian Bader, Fabian Hosp, Matthias Mann, Thomas Arzberger, Rüdiger Klein, Sabine Liebscher,[...]. Sci Rep 2019
21
2
16

Nerve cell loss in the thalamic mediodorsal nucleus in Huntington's disease.
H Heinsen, U Rüb, M Bauer, G Ulmar, B Bethke, M Schüler, F Böcker, W Eisenmenger, M Götz, H Korr,[...]. Acta Neuropathol 1999
71
2
16

Detection of Huntington's disease decades before diagnosis: the Predict-HD study.
J S Paulsen, D R Langbehn, J C Stout, E Aylward, C A Ross, M Nance, M Guttman, S Johnson, M MacDonald, L J Beglinger,[...]. J Neurol Neurosurg Psychiatry 2008
552
2
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.

Longstocking, LLC. © 2021
Home | About Us | FAQs | Terms & Privacy